Literature DB >> 12616808

Body iron stores and coronary atherosclerosis assessed by coronary angiography.

J Auer1, M Rammer, R Berent, T Weber, E Lassnig, B Eber.   

Abstract

BACKGROUND AND AIM: Epidemiological studies have suggested an association between higher body iron stores and coronary artery disease (CAD), but recent trials have reported conflicting data on the role of ferritin in CAD. To assess these findings, we examined the association between serum ferritin and the angiographic extent of coronary atherosclerosis in consecutive patients referred for coronary angiography. METHODS AND
RESULTS: We studied 100 consecutive white subjects (41 women and 59 men; mean age 63.7 +/- 11.0 years) who underwent coronary angiography. The data collected at baseline included conventional risk factors for coronary artery disease (CAD), lipid and fasting total homocysteine levels, serum ferritin levels and transferrin saturation, and clinical characteristics. Serum ferritin levels and transferrin saturation (serum iron concentration divided by total iron-binding capacity) were used as measures of the amount of circulating iron available to tissues. Two experienced cardiologists blinded to the clinical and laboratory data reviewed the angiographic cinefilms, and defined the angiographic severity of CAD on the basis of the sum of three vessel scorring systems. The risk of CAD assessed by coronary angiography was not related to ferritin concentrations or transferrin saturation levels. The estimated relative risk of CAD for the fifth vs the first quintile of serum ferritin was 0.83 (95% CI: 0.63-1.24). Forty of the 100 patients had no or minimal CAD (group A; score 0-3), 33 moderate CAD (group B; score 4-8) and 27 severe CAD (group C; score > 8): the serum ferritin levels in the three groups were respectively 165 +/- 126, 167 +/- 121 and 164 +/- 110 ng/ml, and did not represent an independent risk factor for CAD (p = 0.98). Transferrin saturation in the three groups was 22.9 +/- 10%, 21 +/- 9% and 19.9 +/- 10%, with no significant relationship to the severity of CAD (p = 0.23). The presence of angiographic CAD was associated with patient age (p = 0.048), male gender (p < 0.01), high lowdensity lipoprotein cholesterol levels (p = 0.02), low high-density lipoprotein cholesterol levels (p = 0.02), high plasma fibrinogen levels (p < 0.01) and high fasting total homocysteine levels (p = 0.04).
CONCLUSION: In patients referred for coronary angiography, higher ferritin concentrations and transferrin saturation levels were not associated with an increased extent of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12616808

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  10 in total

Review 1.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

2.  Iron replacement therapy in the routine management of blood donors.

Authors:  Barbara J Bryant; Yu Ying Yau; Sarah M Arceo; Jennifer Daniel-Johnson; Julie A Hopkins; Susan F Leitman
Journal:  Transfusion       Date:  2011-12-29       Impact factor: 3.157

3.  Iron status is associated with carotid atherosclerotic plaques in middle-aged adults.

Authors:  Namanjeet Ahluwalia; Annelise Genoux; Jean Ferrieres; Bertrand Perret; Marion Carayol; Ludovic Drouet; Jean-Bernard Ruidavets
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

Review 4.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

5.  A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity.

Authors:  Michael Sponder; Monika Fritzer-Szekeres; Rodrig Marculescu; Brigitte Litschauer; Jeanette Strametz-Juranek
Journal:  Vasc Health Risk Manag       Date:  2014-11-07

6.  Body iron stores had no impact on coronary heart disease outcomes: a middle-aged male cohort from the general population with 21-year follow-up.

Authors:  Salim Bary Barywani; Erik Östgärd Thunström; Zacharias Mandalenakis; Per-Olof Hansson
Journal:  Open Heart       Date:  2022-04

7.  Association of body iron status with the risk of premature acute myocardial infarction in a Pakistani population.

Authors:  Mohammad Perwaiz Iqbal; Naseema Mehboobali; Asal Khan Tareen; Mohsin Yakub; Saleem Perwaiz Iqbal; Khalida Iqbal; Ghulam Haider
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 8.  Iron and thrombosis.

Authors:  Massimo Franchini; Giovanni Targher; Martina Montagnana; Giuseppe Lippi
Journal:  Ann Hematol       Date:  2007-12-08       Impact factor: 3.673

9.  The relation between body iron store and ferritin, and coronary artery disease.

Authors:  Ali Pourmoghaddas; Hamid Sanei; Mohammad Garakyaraghi; Fatemeh Esteki-Ghashghaei; Maryam Gharaati
Journal:  ARYA Atheroscler       Date:  2014-01

10.  Sex-Specific Genetically Predicted Iron Status in relation to 12 Vascular Diseases: A Mendelian Randomization Study in the UK Biobank.

Authors:  Fangkun Yang; Qinyi Bao; Zhuo Wang; Menghuai Ma; Jinlian Shen; Feiming Ye; Xiaojie Xie
Journal:  Biomed Res Int       Date:  2020-10-26       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.